Rentschler Biopharma is a leading global Contract Development and Manufacturing Organization (CDMO), focused exclusively on client projects. Thanks to our 50 years of proven scientific expertise in biotechnology and our passion for what we do, we count ourselves among the leaders in the industry and make an essential contribution to the global availability of biopharmaceuticals.
Our ethos and DNA is transcribed to Rentschler ATMP, the trusted CDMO of choice, for the development and delivery of high-quality cell and gene therapies. Our history of excellence in cGMP manufacturing and bioprocess development, based on uncompromising quality standards, offers confidence as a partner with a strong strategic approach, ability to scale-up and get therapeutics to market quickly. We treat client projects as if they were our own, applying unmatched knowledge in biopharmaceutical production and CMC requirements. Our experience in approval strategies at an international level ensures that all products are documented in accordance with international regulatory requirements.
Our Center of Excellence for cell and gene therapy is located in Europe’s largest cell and gene therapy cluster — centered around Stevenage, U.K. This provides us, and our clients, access to top talent and key supporting services like suppliers and contract laboratories. At Rentschler ATMP, we are dedicated to advancing cell and gene therapy products from development to cGMP manufacturing for our clients and their patients.